BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11251894)

  • 1. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis.
    Freedman DO; Plier DA; De Almeida AB; De Oliveira AL; Miranda J; Braga C
    Trop Med Int Health; 2001 Jan; 6(1):37-41. PubMed ID: 11251894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural analysis of microfilariae of Wuchereria bancrofti obtained from persistent carriers after repeated courses of diethylcarbamazine.
    Alves LC; Cavalcanti MG; Araújo HR; Silva GM; Veras DL; Paiva MH; Brayner FA
    Micron; 2009; 40(5-6):659-64. PubMed ID: 19359187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
    Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
    Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
    Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
    Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
    Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of treatment with 300 mg oral-dose diethylcarbamazine on nocturnally periodic Wuchereria bancrofti microfilaremia and antigenemia.
    Siriaut C; Bhumiratana A; Koyadun S; Anurat K; Satitvipawee P
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):832-40. PubMed ID: 16295533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin.
    Eberhard ML; Hightower AW; Addiss DG; Lammie PJ
    Am J Trop Med Hyg; 1997 Oct; 57(4):483-6. PubMed ID: 9347968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
    Nicolas L; Plichart C; Nguyen LN; Moulia-Pelat JP
    J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis.
    Figueredo-Silva J; Jungmann P; Norões J; Piessens WF; Coutinho A; Brito C; Rocha A; Dreyer G
    Trans R Soc Trop Med Hyg; 1996; 90(2):192-4. PubMed ID: 8761588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of microfilaraemia & antigenaemia status by Og(4)C(3) ELISA in bancroftian filariasis.
    Malla N; Elango A; Pani SP; Mahajan RC
    Indian J Med Res; 2007 Dec; 126(6):567-74. PubMed ID: 18219085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
    Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
    Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
    da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
    Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
    Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
    Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.
    Ramaiah KD; Vanamail P; Pani SP; Das PK
    Ann Trop Med Parasitol; 2003 Oct; 97(7):737-41. PubMed ID: 14613632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia.
    Simonsen PE; Magesa SM; Meyrowitsch DW; Malecela-Lazaro MN; Rwegoshora RT; Jaoko WG; Michael E
    Trans R Soc Trop Med Hyg; 2005 Jul; 99(7):541-7. PubMed ID: 15869771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
    Koyadun S; Bhumiratana A; Prikchu P
    Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM; Weil GJ; Jayasinghe KS; Premaratne UN; Abeyewickreme W; Rajaratnam HN; Sheriff MH; Perera CS; Dissanaike AS
    Trans R Soc Trop Med Hyg; 1996; 90(6):684-8. PubMed ID: 9015519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
    Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
    J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clearance of circulating filarial antigen as a measure of the macrofilaricidal activity of diethylcarbamazine in Wuchereria bancrofti infection.
    McCarthy JS; Guinea A; Weil GJ; Ottesen EA
    J Infect Dis; 1995 Aug; 172(2):521-6. PubMed ID: 7622896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and intensity of Wuchereria bancrofti antigenaemia in Sri Lanka by Og4C3 ELISA using filter paper-absorbed whole blood.
    Weerasooriya MV; Gunawardena NK; Itoh M; Qiu XG; Kimura E
    Trans R Soc Trop Med Hyg; 2002; 96(1):41-5. PubMed ID: 11925989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.